Adverse reactions caused by Antiparkinsonians
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Interfaces Científicas. Saúde e Ambiente (Online) |
Texto Completo: | https://periodicos.set.edu.br/saude/article/view/139 |
Resumo: | Parkinson disease (PD) usually affects the elderly population who mostly has multiple health problems and makes use of many drugs, so there is a high probability of occurrence of adverse events. This study aims to identify and characterize the medication which is used and the adverse reactions which are presented by patients who suffer from this disease, and who are assisted by the Exceptional Drug Program (EDP) in the 15th Regional Health of Paraná. The study was conducted between August 2008 and July 2009. The archives of EDP were used to identify patients with PD. Home visits were conducted to collect data. Of the 28 interviewed patients, 19 (67.9%) were men and nine (32.1%) were women. The average age of patients was 64.9 years old, 21,43% of patients make use of levodopa / benserasida associated with pramipexole. 17.86% of the patients used pramipexole, and that was the second most used treatment. Of the 28 patients who were interviewed, 16 (57.15%) have or have had some adverse reaction. 14 forms of adverse reactions have been reported, and the most frequent ones were dry mouth (6 cases - 17.65%), orthostatic hypotension (5 cases - 14.70%) and epigastric pain (4 cases - 11.76%). Through the collected data it is observed that most patients make use of several drugs and great part of them have or have had adverse drug reactions, showing that these patients need a careful orientation so that, in spite of the difficulties, they can continue with the treatment. |
id |
UNIT-1_a0f9d16b9a761b03c07f6bfe438483aa |
---|---|
oai_identifier_str |
oai:ojs.emnuvens.com.br:article/139 |
network_acronym_str |
UNIT-1 |
network_name_str |
Interfaces Científicas. Saúde e Ambiente (Online) |
repository_id_str |
|
spelling |
Adverse reactions caused by AntiparkinsoniansReacciones adversas causadas por AntiparkinsonianosReações adversas causadas por antiparkinsonianosDrug toxicityParkinson DiseaseExceptional DrugsToxicidad de medicamentosEnfermedad de Parkinsonmedicamentos excepcionalesToxicidade de DrogaDoença de ParkinsonMedicamentos Excepcionais.Parkinson disease (PD) usually affects the elderly population who mostly has multiple health problems and makes use of many drugs, so there is a high probability of occurrence of adverse events. This study aims to identify and characterize the medication which is used and the adverse reactions which are presented by patients who suffer from this disease, and who are assisted by the Exceptional Drug Program (EDP) in the 15th Regional Health of Paraná. The study was conducted between August 2008 and July 2009. The archives of EDP were used to identify patients with PD. Home visits were conducted to collect data. Of the 28 interviewed patients, 19 (67.9%) were men and nine (32.1%) were women. The average age of patients was 64.9 years old, 21,43% of patients make use of levodopa / benserasida associated with pramipexole. 17.86% of the patients used pramipexole, and that was the second most used treatment. Of the 28 patients who were interviewed, 16 (57.15%) have or have had some adverse reaction. 14 forms of adverse reactions have been reported, and the most frequent ones were dry mouth (6 cases - 17.65%), orthostatic hypotension (5 cases - 14.70%) and epigastric pain (4 cases - 11.76%). Through the collected data it is observed that most patients make use of several drugs and great part of them have or have had adverse drug reactions, showing that these patients need a careful orientation so that, in spite of the difficulties, they can continue with the treatment.La Enfermedad de Parkinson (EP) en general afecta a la población de edad avanzada, que, en su mayoría, tiene múltiples problemas de salud y hace uso de muchas drogas, por lo que hay una alta probabilidad de ocurrencia de eventos adversos. Este estudio tiene como objetivo identificar y caracterizar los medicamentos y reacciones adversas presentadas por los portadores de esta enfermedad, asistidos por el Programa de Medicamentos Excepcionales (PME) en la 15ª Regional de Salud de Paraná. El estudio se realizó entre agosto de 2008 y julio de 2009. Los archivos del PME fueron utilizados para identificar a los pacientes con EP. Las visitas domiciliarias se realizaron para recoger datos. De los 28 pacientes entrevistados, 19 (67,9%) eran hombres y nueve (32,1%) mujeres. La edad media de los pacientes fue de 64,9 años. La mayoría de los pacientes, el 21,43% hace uso de la levodopa/benserasida asociado con pramipexol. Con el 17,86% de los pacientes, el uso de pramipexol es el segundo tratamiento más utilizado. De los 28 pacientes entrevistados, 16 (57,15%) tienen o han tenido una reacción adversa. Se han notificado 14 reacciones adversas, siendo las más frecuentes boca en seco (6 casos - 17,65%), hipotensión ortostática (5 casos - 14,70%) y dolor epigástrico (4 casos - 11,76%). Los datos recogidos muestran que la mayoría de los pacientes hacen uso de varios medicamentos y muchos tienen o han tenido reacciones adversas a los medicamentos, lo que demuestra la necesidad de orientación cuidadosa de estos pacientes que, a pesar de las dificultades, siguen el tratamiento.A Doença de Parkinson (DP) acomete geralmente a população idosa que em sua maioria apresenta múltiplos problemas de saúde e faz uso de vários medicamentos, havendo assim uma grande probabilidade da ocorrência de eventos adversos. Este trabalho tem como objetivo identificar e caracterizar os medicamentos utilizados e as reações adversas apresentadas por portadores deste agravo, atendidos pelo Programa de Medicamentos Excepcionais (PME) da 15a Regional de Saúde do Paraná. O estudo foi realizado entre Agosto de 2008 e Julho de 2009. Os arquivos do PME foram utilizados para identificar os pacientes com DP. Foram realizadas visitas domiciliares para a coleta de dados. Dos 28 pacientes entrevistados, 19 (67,9%) eram homens e nove (32,1%) eram mulheres. A média de idade dos pacientes foi de 64,9 anos. A maioria dos pacientes, 21,43% faz uso de levodopa/benserasida associada ao pramipexol. Com 17,86% dos pacientes, o uso de apenas pramipexol é o segundo esquema de tratamento mais utilizado. Dos 28 pacientes entrevistados, 16 (57,15%) apresentam ou apresentaram alguma reação adversa. Foram relatadas 14 formas de reações adversas, sendo as mais freqüentes xerostomia (6 casos – 17,65%), hipotensão ortostática (5 casos – 14,70%) e dor epigástrica (4 casos – 11,76%). Através dos dados coletados observa-se que grande parte dos pacientes faz uso de vários medicamentos e muitos apresentam ou já apresentaram reações adversas a medicamentos, o que demonstra a necessidade de uma orientação cuidadosa a esses pacientes para que, apesar das dificuldades, continuem o tratamento.Editora Universitária Tiradentes2012-09-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.set.edu.br/saude/article/view/13910.17564/2316-3798.2012v1n1p73-81Interfaces Científicas - Saúde e Ambiente; v. 1 n. 1 (2012); 73-812316-37982316-331310.17564/2316-3798.2012v1n1reponame:Interfaces Científicas. Saúde e Ambiente (Online)instname:Universidade Tiradentes (UNIT)instacron:UNITporhttps://periodicos.set.edu.br/saude/article/view/139/10610.17564/2316-3798.2012v1n1p73-81cLopes, Mariana AparecidaTanaka, Érica MayumiNishiyama, Paulainfo:eu-repo/semantics/openAccess2020-11-17T19:32:53Zoai:ojs.emnuvens.com.br:article/139Revistahttps://periodicos.set.edu.br/saudePRIhttps://periodicos.set.edu.br/index.php/saude/oai||crismporto@gmail.com||interfaces_saude_editor@yahoo.com.br2316-37982316-3313opendoar:2020-11-17T19:32:53Interfaces Científicas. Saúde e Ambiente (Online) - Universidade Tiradentes (UNIT)false |
dc.title.none.fl_str_mv |
Adverse reactions caused by Antiparkinsonians Reacciones adversas causadas por Antiparkinsonianos Reações adversas causadas por antiparkinsonianos |
title |
Adverse reactions caused by Antiparkinsonians |
spellingShingle |
Adverse reactions caused by Antiparkinsonians Lopes, Mariana Aparecida Drug toxicity Parkinson Disease Exceptional Drugs Toxicidad de medicamentos Enfermedad de Parkinson medicamentos excepcionales Toxicidade de Droga Doença de Parkinson Medicamentos Excepcionais. |
title_short |
Adverse reactions caused by Antiparkinsonians |
title_full |
Adverse reactions caused by Antiparkinsonians |
title_fullStr |
Adverse reactions caused by Antiparkinsonians |
title_full_unstemmed |
Adverse reactions caused by Antiparkinsonians |
title_sort |
Adverse reactions caused by Antiparkinsonians |
author |
Lopes, Mariana Aparecida |
author_facet |
Lopes, Mariana Aparecida Tanaka, Érica Mayumi Nishiyama, Paula |
author_role |
author |
author2 |
Tanaka, Érica Mayumi Nishiyama, Paula |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Lopes, Mariana Aparecida Tanaka, Érica Mayumi Nishiyama, Paula |
dc.subject.por.fl_str_mv |
Drug toxicity Parkinson Disease Exceptional Drugs Toxicidad de medicamentos Enfermedad de Parkinson medicamentos excepcionales Toxicidade de Droga Doença de Parkinson Medicamentos Excepcionais. |
topic |
Drug toxicity Parkinson Disease Exceptional Drugs Toxicidad de medicamentos Enfermedad de Parkinson medicamentos excepcionales Toxicidade de Droga Doença de Parkinson Medicamentos Excepcionais. |
description |
Parkinson disease (PD) usually affects the elderly population who mostly has multiple health problems and makes use of many drugs, so there is a high probability of occurrence of adverse events. This study aims to identify and characterize the medication which is used and the adverse reactions which are presented by patients who suffer from this disease, and who are assisted by the Exceptional Drug Program (EDP) in the 15th Regional Health of Paraná. The study was conducted between August 2008 and July 2009. The archives of EDP were used to identify patients with PD. Home visits were conducted to collect data. Of the 28 interviewed patients, 19 (67.9%) were men and nine (32.1%) were women. The average age of patients was 64.9 years old, 21,43% of patients make use of levodopa / benserasida associated with pramipexole. 17.86% of the patients used pramipexole, and that was the second most used treatment. Of the 28 patients who were interviewed, 16 (57.15%) have or have had some adverse reaction. 14 forms of adverse reactions have been reported, and the most frequent ones were dry mouth (6 cases - 17.65%), orthostatic hypotension (5 cases - 14.70%) and epigastric pain (4 cases - 11.76%). Through the collected data it is observed that most patients make use of several drugs and great part of them have or have had adverse drug reactions, showing that these patients need a careful orientation so that, in spite of the difficulties, they can continue with the treatment. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-09-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.set.edu.br/saude/article/view/139 10.17564/2316-3798.2012v1n1p73-81 |
url |
https://periodicos.set.edu.br/saude/article/view/139 |
identifier_str_mv |
10.17564/2316-3798.2012v1n1p73-81 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.set.edu.br/saude/article/view/139/106 10.17564/2316-3798.2012v1n1p73-81c |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Editora Universitária Tiradentes |
publisher.none.fl_str_mv |
Editora Universitária Tiradentes |
dc.source.none.fl_str_mv |
Interfaces Científicas - Saúde e Ambiente; v. 1 n. 1 (2012); 73-81 2316-3798 2316-3313 10.17564/2316-3798.2012v1n1 reponame:Interfaces Científicas. Saúde e Ambiente (Online) instname:Universidade Tiradentes (UNIT) instacron:UNIT |
instname_str |
Universidade Tiradentes (UNIT) |
instacron_str |
UNIT |
institution |
UNIT |
reponame_str |
Interfaces Científicas. Saúde e Ambiente (Online) |
collection |
Interfaces Científicas. Saúde e Ambiente (Online) |
repository.name.fl_str_mv |
Interfaces Científicas. Saúde e Ambiente (Online) - Universidade Tiradentes (UNIT) |
repository.mail.fl_str_mv |
||crismporto@gmail.com||interfaces_saude_editor@yahoo.com.br |
_version_ |
1800220507936653312 |